IMR Press / FBL / Volume 29 / Issue 2 / DOI: 10.31083/j.fbl2902054
Open Access Review
Regulation of Sirtuins in Sepsis-Induced Myocardial Damage: The Underlying Mechanisms for Cardioprotection
Zuowei Pei1,2,*,†Wei Yao3,†Shuo Wang3Yaoxin Wu2
Show Less
1 Department of Cardiology, Central Hospital of Dalian University of Technology, 116033 Dalian, Liaoning, China
2 Faculty of Medicine, Dalian University of Technology, 116024 Dalian, Liaoning, China
3 Department of Internal Medicine, Affiliated Zhong Shan Hospital of Dalian University, 116001 Dalian, Liaoning, China
*Correspondence: pzw_dl@163.com (Zuowei Pei)
These authors contributed equally.
Front. Biosci. (Landmark Ed) 2024, 29(2), 54; https://doi.org/10.31083/j.fbl2902054
Submitted: 20 June 2023 | Revised: 18 September 2023 | Accepted: 27 September 2023 | Published: 4 February 2024
Copyright: © 2024 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract

Sepsis is defined as “a life-threatening organ dysfunction caused by a dysregulated host response to infection”. Although the treatment of sepsis has evolved rapidly in the last few years, the morbidity and mortality of sepsis in clinical treatment are still climbing. Sirtuins (SIRTs) are a highly conserved family of histone deacetylation involved in energy metabolism. There are many mechanisms of sepsis-induced myocardial damage, and more and more evidence show that SIRTs play a vital role in the occurrence and development of sepsis-induced myocardial damage, including the regulation of sepsis inflammation, oxidative stress and metabolic signals. This review describes our understanding of the molecular mechanisms and pathophysiology of sepsis-induced myocardial damage, with a focus on disrupted SIRTs regulation. In addition, this review also describes the research status of related therapeutic drugs, so as to provide reference for the treatment of sepsis.

Keywords
sirtuins
sepsis
myocardial damage
mitochondria
inflammation
Funding
2023JH2/101300098/Liaoning Province Applied Basic Research Program
BW20220302/Beijing Jiekai Cardiovascular Health Foundation
Figures
Fig. 1.
Share
Back to top